Chemical Industries Far East (C05) H1 2026 earnings summary

Executive summary

• H1 FY2026 revenue fell 9.9% YoY to $29.7m amid weak industrial demand; net loss widened to $2.3m from $0.6m.

• Cash and cash equivalents declined to $16.6m from $23.5m at 31 March 2025, while total equity decreased to $103.8m from $106.2m.

Financial highlights

• Gross profit was $3.45m versus $4.66m YoY; gross margin was 12%, down from 14%, amid competition and partially offsetting cost savings.

• Loss before tax widened to $2.12m from $0.41m; income tax expense rose to $0.19m from $0.15m, resulting in a $2.32m net loss versus $0.56m.

• Other income declined 35.1% YoY to $0.84m; other expenses of $0.78m included $0.60m FX losses, $0.10m investment-property fair-value loss, $0.05m financial-asset fair-value loss and a $0.03m onerous-contract provision.

• Net operating cash outflow was $1.70m versus $3.59m generated a year earlier; total net cash outflow was $7.19m versus $4.36m.

Outlook and guidance

• Priorities include improving safety culture, risk management and operational excellence, while pursuing business partnerships and sustainability initiatives to support profitable, sustainable operations.

• Organizational rightsizing, process-excellence work, cost controls and customer-service improvements are continuing.